UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract MS01-2: Artificial receptors and the cellular therapy of breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.MS01-2-MS01-2

Brenner, MK

2013

Volltextzugriff (PDF)

A Distinct "Side Population" of Cells with High Drug Efflux Capacity in Human Tumor Cells

Proceedings of the National Academy of Sciences - PNAS, 2004-09, Vol.101 (39), p.14228-14233

2004

Volltextzugriff (PDF)

A Chimeric T Cell Antigen Receptor that Augments Cytokine Release and Supports Clonal Expansion of Primary Human T Cells

Molecular therapy, 2005-11, Vol.12 (5), p.933-941

2005

Volltextzugriff (PDF)

An inducible caspase 9 safety switch for T-cell therapy

Blood, 2005-06, Vol.105 (11), p.4247-4254

2005

Volltextzugriff (PDF)

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

The Journal of experimental medicine, 2004-12, Vol.200 (12), p.1623-1633

2004

Volltextzugriff (PDF)

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

Blood, 2005-03, Vol.105 (5), p.1898-1904

2005

Volltextzugriff (PDF)

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals

Gene therapy, 2013-09, Vol.20 (9), p.958-962

2013

Volltextzugriff (PDF)

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

Nature medicine, 1999-03, Vol.5 (3), p.309-313

1999

Volltextzugriff (PDF)

Prompt versus preemptive intervention for EBV lymphoproliferative disease

Blood, 2004-05, Vol.103 (10), p.3979-3981

2004

Volltextzugriff (PDF)

Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta

Blood, 2001-03, Vol.97 (5), p.1227-1231

2001

Volltextzugriff (PDF)

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

Blood, 2001-08, Vol.98 (4), p.1166-1173

2001

Volltextzugriff (PDF)

Antigen-induced regulatory T cells

Blood, 2004-07, Vol.104 (1), p.26-33

2004

Volltextzugriff (PDF)

Genetic Modification of T Lymphocytes for Adoptive Immunotherapy

Molecular therapy, 2004-07, Vol.10 (1), p.5-18

2004

Volltextzugriff (PDF)

Adapting a transforming growth factor β–related tumor protection strategy to enhance antitumor immunity

Blood, 2002-05, Vol.99 (9), p.3179-3187

2002

Volltextzugriff (PDF)

Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus

The Journal of infectious diseases, 1998-11, Vol.178 (5), p.1257-1262

1998

Volltextzugriff (PDF)

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

The Journal of experimental medicine, 2004-02, Vol.199 (4), p.459-470

2004

Volltextzugriff (PDF)

Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

Blood, 1998-09, Vol.92 (5), p.1549-1555

1998

Volltextzugriff (PDF)

Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer

Prostate cancer and prostatic diseases, 2013-06, Vol.16 (2), p.123-131

2013

Volltextzugriff (PDF)

Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells

Blood, 2003-11, Vol.102 (10), p.3815-3821

2003

Volltextzugriff (PDF)

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells

Blood, 2004-10, Vol.104 (8), p.2432-2440

2004

Volltextzugriff (PDF)

Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

Blood, 2002-03, Vol.99 (6), p.2009-2016

2002

Volltextzugriff (PDF)

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

Blood, 2001-02, Vol.97 (4), p.835-843

2001

Volltextzugriff (PDF)

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation

Blood, 2000-02, Vol.95 (4), p.1502-1505

2000

Volltextzugriff (PDF)

A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy

Cell cycle (Georgetown, Tex.), 2005-02, Vol.4 (2), p.203-205

2005

Volltextzugriff (PDF)

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

Nature medicine, 1996-05, Vol.2 (5), p.551-555

1996

Volltextzugriff (PDF)

1 – 25 von 271

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(212)

Publikationsform

Sprache

Englisch
(271)

Erscheinungsjahr

n.n

Thema

Science & Technology
(242)
Life Sciences & Biomedicine
(211)
Humans
(194)
Biological And Medical Sciences
(104)
Hematology
(90)
Medical Sciences
(87)
Medicine, Research & Experimental
(59)
Research & Experimental Medicine
(59)
Female
(58)
Oncology
(55)
Bone Marrow Transplantation
(50)
Immunology
(50)
Male
(49)
Biotechnology & Applied Microbiology
(45)
Adult
(43)
Child
(43)
Adolescent
(40)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(38)
Animals
(38)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(47)
Human Gene Therapy
(16)
Bone Marrow Transplantation
(14)
The Lancet
(9)
Cytotherapy
(7)
Molecular Therapy
(7)
British Journal Of Haematology
(6)
Clinical And Experimental Immunology
(5)
The Journal Of Immunology
(5)
British Journal Of Cancer
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract MS01-2: Artificial receptors and the cellular therapy of breast cancer

A Distinct "Side Population" of Cells with High Drug Efflux Capacity in Human Tumor Cells

A Chimeric T Cell Antigen Receptor that Augments Cytokine Release and Supports Clonal Expansion of Primary Human T Cells

An inducible caspase 9 safety switch for T-cell therapy

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

Prompt versus preemptive intervention for EBV lymphoproliferative disease

Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

Antigen-induced regulatory T cells

Genetic Modification of T Lymphocytes for Adoptive Immunotherapy

Adapting a transforming growth factor β–related tumor protection strategy to enhance antitumor immunity

Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer

Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells

Epstein-Barr virus–specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation

A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

Suchergebnisse filtern